ArticleBioprocess and biosystems engineering2026
Eco-friendly synthesis of ZnO nanostructures from yeast strains isolated from kombucha and beetroot kwass for antimicrobial thin film applications.
Article in Bioprocess and biosystems engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing demand for sustainable antimicrobial materials has accelerated the development of environmentally friendly synthesis strategies that minimize the use of hazardous chemicals and energy-intensive processes. However, the application of unconventional yeast strains for integrated nanoparticle production and thin film fabrication remains largely unexplored. In this study, yeast strains isolated from kombucha and beetroot kvass were employed for the extracellular biosynthesis of zinc oxide nanoparticles (ZnO NPs), followed by thin film fabrication, enabling systematic investigation of structure-property-antibacterial relationships. This approach provides a sustainable route for developing biologically derived antimicrobial materials with potential relevance to food and biomedical applications. ZnO NPs were synthesized and deposited as thin films via spin coating. Ultraviolet-visible spectroscopy (UV-Vis) confirmed nanoparticle formation, while scanning electron microscopy (SEM) revealed agglomerated nanoparticles and homogeneous nanoscale films. Energy-dispersive X-ray spectroscopy (EDX) verified elemental composition, and X-ray diffraction (XRD) analysis identified monoclinic and cubic crystalline phases with crystallite sizes ranging from 8.78 to 19.40 nm, whereas thin films displayed predominantly amorphous characteristics. Fourier transform infrared spectroscopy (FTIR) identified characteristic absorption bands associated with Zn-O vibrations and surface functional groups. Water contact angle (WCA) analysis indicated hydrophilic surfaces. ZnO NPs exhibited pronounced antibacterial activity against Staphylococcus aureus ATCC 6538P and Escherichia coli O157:H7. Although thin films produced smaller inhibition zones, complete bacterial inactivation was achieved within 2 h under direct-contact conditions. These findings demonstrate the potential of biosynthesized ZnO nanostructures as sustainable antimicrobial platforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.